Latest Conference Articles

Key Drugs in Specialty Pharmacy Slated to Launch in 2022

Key Drugs in Specialty Pharmacy Slated to Launch in 2022

November 26th 2021, 2:00pm

Asembia Specialty Pharmacy Summit

Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, discusses key drugs in development that are slated to launch in 2022.

The Role of Setting in Patient Care During the Treatment of Burkitt Lymphoma

The Role of Setting in Patient Care During the Treatment of Burkitt Lymphoma

November 11th 2021, 2:00pm

Society of Hematologic Oncology (SOHO) Annual Meeting

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the role setting has in the care of patients with Burkitt lymphoma.

How the Care Setting Can Impact Patient Outcomes in the Treatment of Burkitt Lymphoma

How the Care Setting Can Impact Patient Outcomes in the Treatment of Burkitt Lymphoma

November 10th 2021, 2:00pm

Society of Hematologic Oncology (SOHO) Annual Meeting

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses how the care setting can impact patient outcomes in the treatment of Burkitt lymphoma.

Rate of Treatment-Related Mortality, Most Common Causes in the Treatment of Burkitt Lymphoma

Rate of Treatment-Related Mortality, Most Common Causes in the Treatment of Burkitt Lymphoma

November 9th 2021, 2:00pm

Society of Hematologic Oncology (SOHO) Annual Meeting

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the rate of treatment-related mortality and the most common causes in the treatment of Burkitt lymphoma.

The Role of Nrf2, Vitamin K in DNA Damage Signaling, Senescence, Inflammaging

The Role of Nrf2, Vitamin K in DNA Damage Signaling, Senescence, Inflammaging

November 8th 2021, 9:00pm

American Society of Nephrology (ASN) Kidney Week

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the role of Nrf2 and vitamin K in DNA damage signaling, senescence, and inflammaging.

Assessing the Link Between Senescence, Early Vascular Aging in Patients With Chronic Kidney Disease

Assessing the Link Between Senescence, Early Vascular Aging in Patients With Chronic Kidney Disease

November 8th 2021, 7:00pm

American Society of Nephrology (ASN) Kidney Week

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the link between senescence and early vascular aging in the context of chronic kidney disease.

How to Counteract the Contributing Factors to Early Vascular Aging

How to Counteract the Contributing Factors to Early Vascular Aging

November 8th 2021, 5:00pm

American Society of Nephrology (ASN) Kidney Week

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what may be some of the contributing factors to early vascular aging and how might they be counteracted.

How Specialty Pharmacies Can Support Palliative Care During Cancer Treatment

How Specialty Pharmacies Can Support Palliative Care During Cancer Treatment

November 8th 2021, 3:00pm

National Pharmaceutical Association Annual Convention

Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how palliative care can support the cancer treatment process, and how specialty pharmacies can support this type of care.

Identifying, Developing Novel, Effective Therapies for Vascular Calcification, Early Vascular Aging

Identifying, Developing Novel, Effective Therapies for Vascular Calcification, Early Vascular Aging

November 8th 2021, 3:00pm

American Society of Nephrology (ASN) Kidney Week

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the next steps to identify and develop novel and effective therapeutic targets for vascular calcification and early vascular aging.

Factors Associated With Progression-free Survival, Overall Survival in the Treatment of Burkitt Lymphoma

Factors Associated With Progression-free Survival, Overall Survival in the Treatment of Burkitt Lymphoma

November 8th 2021, 1:30pm

Society of Hematologic Oncology (SOHO) Annual Meeting

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the factors associated with progression-free survival and overall survival in the treatment of Burkitt lymphoma.